Why Smart Eye Surgeons Still Make Bad Growth Decisions - Summary - MDSpire
Commentary & Perspectives

Why Smart Eye Surgeons Still Make Bad Growth Decisions

You’re not making poor decisions; you’re being forced to decide without clear, trustworthy data across your patient journey

Share

Surgeons excel in precise decision-making in surgery, relying on clear diagnostics and structured protocols. However, many are forced to rely on fragmented and misleading data in their practice's business side, leading to ineffective growth strategies. Instead of guessing based on limited information from marketing metrics, a comprehensive, end-to-end growth scorecard is proposed. It focuses on tracking a few key metrics that connect to meaningful outcomes, thereby allowing practitioners to make informed decisions and optimize their revenue cycle effectively.

Original Source(s)

Why Smart Eye Surgeons Still Make Bad Growth Decisions

  • by Rod Solar

  • April 30, 2026

Related Content

Japan Debuts Novel Dry Eye Therapy

Senju Pharmaceutical launches the first TRPV1 antagonist for dry eye in Japan

  • April 30, 2026

  • 3 min
The New Era of Postoperative Inflammation Management

What surgeons need to know about managing post-cataract inflammation

Optogenetic RP Therapy Gains RMAT

Ray Therapeutics secures FDA RMAT designation for its optogenetic retinitis pigmentosa therapy

  • April 29, 2026

  • 2 min